HCP Announces Results for the Fourth Quarter and Year Ended December 31, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Stifel Downgrades HCP (HCP) to Sell
February 11, 2016 7:17 AM ESTStifel downgraded HCP (NYSE: HCP) from Hold to Sell with a price target of $23.00.
For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.
Shares of HCP closed at $27.21 yesterday.
... MoreUBS Cuts Price Target on HCP, Inc. (HCP) as HCR ManorCare (HCRMC) Faces Difficulties
February 10, 2016 10:36 AM ESTUBS maintained a Buy rating on HCP (NYSE: HCP), and cut the price target to $31.00 (from $41.00). UBS estimates a 30% rent cut would improve coverage fixed charge coverage to 1.4x-1.5x at HRCMC, versus the ~1.1x in guidance for 2016. The higher coverage would provide... More
Hilliard Lyons Downgrades HCP (HCP) to Long-Term Buy
February 10, 2016 9:44 AM ESTHilliard Lyons downgraded HCP (NYSE: HCP) from Buy to Long-Term Buy.
For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.
Shares of HCP closed at $28.33 yesterday.
... MoreMizuho Securities Remains Neutral on HCP, Inc. (HCP) - Cuts PT to $26
February 10, 2016 8:15 AM ESTMizuho Securities reiterated a Neutral rating on HCP (NYSE: HCP), and cut the price target to $26.00 (from $37.00). Mizuho believes that HCP is a sideways mover for now, with some possible volatility related to the sell-off on Wednesday. Mizuho analysts remain negatively-biased, despite... More
